- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 6, 2024
Distillery Therapeutics
Targeting cancer cell glycosphingolipid synthesis for antitumor immunity in KRAS-mutant cancers
BioCentury | May 26, 2023
Discovery & Translation
Excision of CGG repeats in fragile X; plus VLP’s saRNA COVID vaccine and more
BioCentury’s roundup of translational news
Items per page:
1 - 9 of 9